Ra Capital Management, L.P. Spero Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$9.69 - $17.79 $7.19 Million - $13.2 Million	-741,647 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$9.96 - $14.61 $4.82 Million - $7.07 Million	-484,000 Reduced 39.49%	741,647 $10.6 Million
Q4 2017 Feb 14, 2018	BUY	$10.43 - $14.75 $12.8 Million - $18.1 Million	1,225,647	1,225,647 $14.4 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $40.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.